SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1501, TG-1701, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in Morrisville, NC.

TG Therapeutics Inc

TGTXs breakout to a fresh 52-week high has traders focused on the upcoming Q3 report and speculation about a potential pharma buyout, with some interpreting the lack of an earnings-date announcement as a clue. The acquisition talk is unconfirmed; bullish sentiment also reflects BRIUMVIs sales growth and anticipated subcutaneous data, while skeptics warn that earnings and commercial executionnot takeover rumorswill determine the story.

Carvana Co. is a holding company and an eCommerce platform, which engages in the buying and selling of used cars. The company was founded by Ernest Garcia, III, Benjamin Huston and Ryan Keeton in 2012 and is headquartered in Tempe, AZ.

Carvana Co. - Ordinary Shares - Class A

Carvana Co.

Carvanas Q3 report, with record revenue and retail-unit growth, alongside the SECs decision to close its investigation without recommending enforcement action, fueled a sharp rally. Bulls point to growth and possible short-covering, while bears focus on the EPS miss, margin pressure, lack of future guidance, and valuation concerns.

Algorand (ALGO) is a cryptocurrency launched in 2019. Algorand has a current supply of 10,000,000,000 with 9,075,967,326.643147 in circulation. The last known price of Algorand is 0.09515711 USD and is down -0.23 over the last 24 hours. It is currently trading on 586 active market(s) with $49,581,617.87 traded over the last 24 hours. More information can be found at http://algorand.foundation.

Algorand

ALGO is drawing attention amid debate over whether its depressed price and rebounds signal a durable bottom or an altcoin-cycle recovery. Bulls point to accumulation potential and Algorands quantum-resistant and tokenization use cases, while bears emphasize its steep long-term losses and repeated failed rallies.

BioNTech SE operates as immunotherapy company, which engages therapies for cancer and other serious diseases. Its product pipeline include BNT162b2, BNT161, BNT164, FixVac, iNeST, RiboMabs, CAR-T Cells, TCRs and Next-Gen CP Immunomodulators. The company was founded by Christopher Huber, Oezlem Tuereci, and Ugur Sahin on June 2, 2008 and is headquartered in Mainz, Germany.

BioNTech SE - ADR

BioNTechs oncology data are driving discussion, particularly a Phase 3 breast-cancer result traders describe as a modest benefit with safety concerns. The reaction is divided: bears see it alongside earlier trial setbacks and leadership uncertainty, while bulls argue the broader pipeline still has potential.

Natera, Inc. is a diagnostics company, which engages in the discovery, development, and commercialization of genetic testing services. It provides Panorama non-invasive prenatal test (NIPT), Vistara, horizon carrier screening (HCS), spectrum pre-implantation genetic screening and spectrum pre-implantation genetic diagnosis, Anora products of conception (POC) and non-invasive paternity testing (PAT). The company was founded by Matthew Rabinowitz and Jonathan Sheena in November 2003 and is headquartered in Austin, TX.

Natera Inc

Natera is drawing attention amid reported insider share sales after a sharp run to record highs, with some traders trimming on concern while others view the sales as routine profit-taking. The discussion also reflects debate over the stocks stretched valuation and whether its growth in genetic testing and oncology diagnostics can sustain the rally.

Amgen, Inc. is a biotechnology company, which engages in the discovery, development, manufacture, and marketing of human therapeutics. The company was founded by William K. Bowes, Jr., Franklin Pitcher Johnson, Jr., George B. Rathmann, and Joseph Rubinfeld on April 8, 1980 and is headquartered in Thousand Oaks, CA.

AMGEN Inc.

Amgens positive Phase 3 lung-cancer data for IMDELLTRA with AstraZenecas IMFINZIshowing a substantial survival benefithas reinforced optimism about its oncology pipeline as shares reach new highs. Traders are also watching the upcoming earnings report and debating whether heavy options activity reflects bullish positioning or hedging.

Almonty Industries, Inc. engages in the mining, processing, and shipment of tungsten concentrates. Its projects include Almonty Korea Tungsten, Panasquiera mine, Gentung, Almonty Korea Moly, Los Santos mine, and Valtreixal. The company was founded on September 28, 2009 and is headquartered in Dillon, MT.

Almonty Industries Inc

ALM is drawing attention as its shares sell off despite traders pointing to firm tungsten prices and Almontys Sangdong mine moving into production. The debate centers on whether the decline reflects broader risk-off pressure and uncertainty about the mines ramp-up, or an opportunity backed by tightening tungsten supply.

Icahn Enterprises LP is a holding company. It operates through the following segments: Investment, Automotive, Energy, Food Packaging, Real Estate, Home Fashion, Pharma, and Holding Company. The Investment segment consists of various private investment funds. The Automotive segment holds ownership in Icahn Automotive Group, LLC. The Energy segment refers to petroleum refining and marketing businesses. The Food Packaging segment involves the production and sale of cellulosic, fibrous, and plastic casings for the processed meat and poultry industry. The Real Estate segment offers rental real estate, property development, and resort activities. The Home Fashion segment deals with manufacturing, sourcing, marketing, distributing, and selling home fashion consumer products. The Pharma segments operate through Vivus, Inc., a specialized pharmaceutical company. The Holding Company segment manages acquisition and investment in operating businesses. The company was founded on February 17, 1987 and is headquartered in Sunny Isles Beach, FL.

Icahn Enterprises L P - Unit

Icahn Enterprises, L.P.

IEP is drawing attention ahead of its quarterly results, with traders focused on whether the distribution will be maintained or cut and how CVR Energys performance and IEPs hedging losses affect its finances. The sharp selloff has fueled anxiety about the payout and the companys outlook, while some holders point to IEPs CVR stake and high short interest as reasons for optimism.

Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. Its product portfolio includes the following brands: Dupixent, Evkeeza, Eylea, Inmazeb, and Kevzara. The firm accelerates the traditional drug development process through its proprietary VelociSuite technologies such as VelocImmune, which uses unique genetically humanized mice to produce optimized fully human antibodies and bispecific antibodies. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, George Damis Yancopoulos, and Eric M. Shooter on January 8, 1988, and is headquartered in Tarrytown, NY.

Regeneron Pharmaceuticals, Inc.

Regenerons strong third-quarter earnings beat, supported by demand for Dupixent and Eylea HD, sparked a sharp rally and a new 52-week high. Traders are broadly upbeat about the breakout, while debating whether the shares can hold their gains or pull back.

Crown Castle, Inc. engages in the business of owning, operating, and leasing shared communications infrastructure. It operates through the following segments: Towers, Fiber, and Other. The Towers segment focuses on providing coverage and capacity for wireless carrier network deployments. The Fiber segment includes communications infrastructure offerings of small cells and fiber solutions. The Other segment is involved in corporate assets such as cash and cash equivalents. The company was founded by Ted B. Miller Jr. and Edward C. Hutcheson Jr. in 1994 and is headquartered in Houston, TX.

Crown Castle Inc

Crown Castle International Corp

Reports that SpaceX is exploring access to thousands of U.S. cell sites have driven attention to Crown Castle, with traders viewing a potential new tenant as a leasing opportunity for tower owners. The discussions remain unconfirmed and no agreement is signed, prompting debate over whether the growth case is real or the rally is based on speculation about SpaceXs wireless ambitions.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Rivulet Entertainment, Inc. is a software development company, which engages in the creation of interface and application solutions for speech recognition technologies. It also focuses on the discussions with a certain firm dedicated to assisting in the commercialization of intellectual assets. The company was founded by Michael K. Davis and Douglas Holt on March 15, 1994 and is headquartered in Scottsdale, AZ.

Rivulet Entertainment Inc

Extremely Bearish Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Current Price	$0.0011
Prev Close	$0.0021
Open	$0.0011
Dividend Yield	N/A
50-Day Moving Average	$0.002
Beta	24.68
Avg. Volume	3.05
PE Ratio	-0.02

52-Week High	$1.00
52-Week Low	$0.0005
Market Capitalization	$122,315.00
EPS (Annual)	N/A
Price to Book	-0.02
Revenue Per Employee	N/A

Feed

News

Sentiment

Fundamentals

Info

AVOI Fundamentals